ID: ALA4635184

Max Phase: Preclinical

Molecular Formula: C34H41N7O6

Molecular Weight: 643.74

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=C(C(N)=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](N)Cc1ccc(O)cc1)c1ccco1

Standard InChI:  InChI=1S/C34H41N7O6/c1-20(31(37)43)30(29-10-6-16-47-29)41-34(46)28(18-22-19-38-26-8-3-2-7-24(22)26)40-33(45)27(9-4-5-15-35)39-32(44)25(36)17-21-11-13-23(42)14-12-21/h2-3,6-8,10-14,16,19,25,27-28,30,38,42H,1,4-5,9,15,17-18,35-36H2,(H2,37,43)(H,39,44)(H,40,45)(H,41,46)/t25-,27+,28-,30+/m0/s1

Standard InChI Key:  UKEKHOFGTGJBKN-RKDXIHMYSA-N

Associated Targets(Human)

Mu opioid receptor 19785 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Delta opioid receptor 3911 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mu opioid receptor 6060 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Kappa opioid receptor 774 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 643.74Molecular Weight (Monoisotopic): 643.3118AlogP: 1.58#Rotatable Bonds: 17
Polar Surface Area: 231.59Molecular Species: BASEHBA: 8HBD: 8
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.42CX Basic pKa: 10.27CX LogP: 0.10CX LogD: -2.03
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.06Np Likeness Score: 0.13

References

1. Zhao L, Luo K, Wang Z, Wang Y, Zhang X, Yang D, Ma M, Zhou J, Cui J, Wang J, Han CZ, Liu X, Wang R..  (2020)  Design, synthesis, and biological activity of new endomorphin analogs with multi-site modifications.,  28  (9): [PMID:32199689] [10.1016/j.bmc.2020.115438]

Source